Avricore Health (AVCRF) Common Equity (2014 - 2025)

Avricore Health has disclosed Common Equity across 12 years of filings, most recently posting $279351.0 for Q4 2025.

• In Q4 2025, Common Equity fell 80.17% year-over-year to $279351.0; the TTM figure through Dec 2025 stood at $279351.0 (down 80.17% YoY), while the FY2025 annual figure was $278819.3, down 80.6% from the prior year.
• Common Equity slipped to $279351.0 in Q4 2025, from $1.4 million in the prior quarter.
• Over the last five years, Common Equity for AVCRF reached as high as $2.0 million in Q1 2021 and fell as low as $279351.0 in Q4 2025.
• The 5-year median for Common Equity is $1.6 million (2023), against an average of $1.5 million.
• Annual changes were most pronounced in 2021 — Common Equity jumped 413.82% — and 2025, when it sank 80.17%.
• A 5-year view of Common Equity shows it stood at $1.7 million in 2021, then retreated by 16.98% to $1.4 million in 2022, then advanced by 1.98% to $1.5 million in 2023, then declined by 4.55% to $1.4 million in 2024, then slumped by 80.17% to $279351.0 in 2025.
• According to Business Quant data, Common Equity over the past three periods registered $279351.0, $1.4 million, and $1.5 million for Q4 2025, Q4 2024, and Q4 2023 respectively.